Trial intelligence / Profile preview

Intraperitoneal meropenem pharmacokinetics during peritoneal dialysis-related peritonitis

TCTR20191121002Completed

Sponsor
Routine to Research Unit
Start
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of meropenem in peritonitis, sponsored by Routine to Research Unit. Primary endpoints: Plasma meropenem concentration at 24 hours and Dialysate meropenem concentration at 24 hours. Started Oct 2017; status: completed.

02

Drugs

meropenem
03

Conditions

peritonitis

Beyond the preview

Go deeper on TCTR20191121002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20191121002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call